Gurnet Point Capital is a private investment firm specializing in life sciences, targeting scientifically de-risked companies to bring treatments to market and enhance patient outcomes. Founded in 2015 and headquartered in Cambridge, MA, the firm employs an active ownership strategy, leveraging its team's extensive operational experience to drive value in its investments.
Recent Transactions involving Gurnet Point Capital
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Gurnet Point Capital and Patient Square Capital Complete Their Acquisition of Radius Health, Inc. |
Radius Health |
Patient Square CapitalGurnet Point Capital |
Pharmaceutical Manufacturing |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →